Prostate cancer news reports: Sunday, July 12, 2009

Posted on July 12, 2009 by Sitemaster

This weekend’s news reports deal with: A new epidemiological database for prostate cancer research Phase II trial results for the “vaccine” PSA: 154-163 (155L) The degree to which adding hormone therapy to radiotherapy affects outcomes in patients with localized prostate cancer The possibility that zoledronic acid could be used just once a year to prevent [...]

Filed under: Drugs in development, Management, Prevention, Treatment | Tagged: , , , , | 5 Comments »

Prostate cancer news reports: Friday, June 12, 2009

Posted on June 12, 2009 by Sitemaster

Todays news reports adddress: Surgeon and hospital volume and outcomes to radical prostatectomy Adverse events associated with the use of hypofractionated, dose-escalated, IMRT Quality of sexual function after external beam radiation therapy Percentage of positive biopsy cores and response to first-line hormone therapy

Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: , , , , , , , , , , , | Leave a Comment »

Prostate cancer news reports: Thursday, June 11, 2009

Posted on June 11, 2009 by Sitemaster

Today’s prostate cancer news report deals with: A recent review of appropriate penile rehabilitation strategies Management of biochemical recurrence after first-line treatment failure Initial use of hormone therapy by French clinicians

Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: , , , , | Leave a Comment »

Hormone therapy and radiation treatment: a topical update

Posted on June 11, 2009 by Sitemaster

There are several recent reports that address factors specific to the combination of hormone therapy with radiation therapy in the management of prostate cancer, so we thought it would be helpful to offer a topical update.

Filed under: Management, Treatment | Tagged: , , , , | 1 Comment »

Prostate cancer news reports: Thursday, May 21, 2009

Posted on May 21, 2009 by Sitemaster

Today’s news reports cover items on: “Elastography” in assessment of risk of prostate cancer Ejaculatory function before and after brachytherapy Hormone therapy for prostate cancer: a 20-year, single institution experience

Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: , , , , , | Leave a Comment »

AUA report and update no. 6: Monday, April 27, 2009

Posted on April 27, 2009 by Sitemaster

We learned a few other interesting tidbits during a variety of sessions and conversations today.

Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Prevention, Risk, Treatment, Uncategorized | Tagged: , , , , , , , , | Leave a Comment »

Tuesday’s news reports: March 24, 2009

Posted on March 23, 2009 by Sitemaster

Comment on an article on PSA velocity and prediction of biopsy outcomes has been provided separately. Today’s other news includes reports on: Pathological outcomes and criteria for active surveillance protocols Outcomes to permanent seed implant brachytherapy: age does not affect outcome Vacuum erectile devices and their value in post-prostatectomy erectile dysfunction Biochemical recurrence post-prostatectomy and [...]

Filed under: Diagnosis, Management, Risk, Treatment | Tagged: , , , , , , , , | Leave a Comment »

The Thursday news reports: March 19, 2009

Posted on March 19, 2009 by Sitemaster

There are six new reports in today’s news, of which the most immediately important would seem to be: How men manage their “fear” while on active surveillance “Cancer anxiety” and early use of hormonal therapy Approval for a Phase III clinical trial of MDV3100

Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: , , , , , , , | Leave a Comment »

Anxiety predicts early use of hormone therapy

Posted on March 4, 2009 by Sitemaster

It is well known to readers of The “New” Prostate Cancer InfoLink that androgen deprivation therapy (ADT) is a commonly used form of treatment for patients who experience biochemical recurrence (BCR) after first- or second-line therapy. However, as is also well known, the optimal timing of ADT initiation is uncertain, and earlier initiation of ADT [...]

Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: , , , , , | 3 Comments »

Watchful waiting, hormone therapy, and quality of life

Posted on March 3, 2009 by Sitemaster

McDermott and Sanda have just published an assessment of the recent re-analysis of the Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4).  This is the study that initially demonstrated a modest but significant survival benefit of prostatectomy over watchful waiting. According to the re-analysis of this study, patients allocated to watchful waiting experienced a significantly [...]

Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: , , , , | 4 Comments »

Hormone therapy + radiotherapy as first-line treatment: how long do you need hormones?

Posted on January 8, 2009 by Sitemaster

Here’s a question that comes up over and over again from newly diagnosed patients: “My doctor is suggesting I get hormones in  combination with radiation therapy. How long am I likely to be on hormone therapy?”

Filed under: Management, Treatment, Uncategorized | Tagged: , , , | 2 Comments »

Hormone therapy with and without radiotherapy in high-risk, localized prostate cancer

Posted on December 16, 2008 by Sitemaster

In September this year, writing from the 50th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), Dr. Eyad Abu-Isa addressed breaking news of a Scandinavian trial comparing radiotherapy + hormone therapy to radiotherapy alone in the treatment of locally advanced prostate cancer. The complete results of this study in were just published [...]

Filed under: Management, Treatment | Tagged: , , | Leave a Comment »

Neoadjuvant hormone therapy in localized and locally advanced prostate cancer

Posted on October 24, 2008 by Sitemaster

The Cochrane Collaboration is a highly respected global network that seeks to improve healthcare decision-making through systematic reviews of the effects of healthcare interventions, published in The Cochrane Library. The Cochrane Urological Cancers Unit has just published a detailed review and assessment of the value of hormone therapy in neoadjuvant management of localized and locally [...]

Filed under: Management, Treatment | Tagged: , , , | Leave a Comment »

« Previous Page
Follow

Get every new post delivered to your Inbox.

Join 325 other followers